
CAS 1185076-44-1
:RALOXIFENE-D4
Description:
RALOXIFENE-D4 is a deuterated form of Raloxifene, a selective estrogen receptor modulator (SERM) primarily used in the treatment and prevention of osteoporosis in postmenopausal women. The deuteration (indicated by the "D4") refers to the substitution of hydrogen atoms with deuterium, a stable isotope of hydrogen, which can enhance the compound's stability and alter its pharmacokinetic properties. Raloxifene itself exhibits estrogenic activity in bone tissue while acting as an antagonist in breast and uterine tissues, making it beneficial for reducing the risk of estrogen-dependent cancers. The chemical structure of RALOXIFENE-D4 retains the core characteristics of Raloxifene, including its ability to bind to estrogen receptors, but the presence of deuterium can improve its metabolic profile in research applications. This compound is often utilized in pharmacokinetic studies and drug development to better understand the behavior of SERMs in biological systems. As with any chemical substance, safety and handling precautions should be observed, and its use should be guided by appropriate regulatory standards.
Formula:C28H23D4NO4S
Synonyms:- RALOXIFENE-D4
- [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]Methanone-d4
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
Raloxifene-d4
CAS:Controlled ProductFormula:C282H4H23NO4SColor and Shape:Yellowish SolidMolecular weight:477.61

